<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD) is an important cause of visual morbidity throughout the world, but shows striking differences in racial predilection </plain></SENT>
<SENT sid="1" pm="."><plain>Despite important advances in the therapeutic management of <z:hpo ids='HP_0011009'>acute</z:hpo> intraocular <z:mp ids='MP_0001845'>inflammation</z:mp>, the long-term impact of these new strategies on visual outcome of BD and their efficacy in different ethnic groups is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>A comparative study of patient characteristics, clinical ocular features and inflammatory score, and current therapy was undertaken on <z:hpo ids='HP_0000001'>all</z:hpo> patients fulfilling the International Study Group criteria for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and the <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's Disease Research Committee of Japan, who attended the <z:hpo ids='HP_0000554'>Uveitis</z:hpo> Clinics of Moorfields Eye Hospital (n=19) and Kurume University School of Medicine (KUS) (n=35) during a continuous consecutive four-week period </plain></SENT>
<SENT sid="3" pm="."><plain>Japanese patients were significantly older (43.2+/-11.8 years) than the patients seen in London (35.4+/-8 </plain></SENT>
<SENT sid="4" pm="."><plain>9 years) </plain></SENT>
<SENT sid="5" pm="."><plain>There was a predominance of male patients in both groups </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients seen in KUS were Japanese, while the patients in London included 12 Caucasians, five Middle Eastern, one African, and one Asian </plain></SENT>
<SENT sid="7" pm="."><plain>No significant differences were seen between the two populations in the duration of <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> or systems affected by the disease, such as mouth <z:mpath ids='MPATH_579'>ulcers</z:mpath>, <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, <z:mp ids='MP_0001212'>skin lesions</z:mp> including <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum, or <z:hpo ids='HP_0001369'>arthritis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The duration of ocular disease was similar in both centres: around seven years </plain></SENT>
<SENT sid="9" pm="."><plain>There was, however, a significant difference in the number of eyes with active <z:hpo ids='HP_0012122'>anterior uveitis</z:hpo> (59.7% KUS vs 18.4% London (chi-square: 5.4; p=0.006)) and/or <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> (31.3% KUS vs 18.4% London (chi-square: 5.42; p&lt;0.02)) </plain></SENT>
<SENT sid="10" pm="."><plain>No significant differences were found in the number of eyes with optic disc swelling or <z:hpo ids='HP_0000648'>optic atrophy</z:hpo> and in each centre the number of eyes with vision greater than 6/9 or worse than 6/60 were the same </plain></SENT>
<SENT sid="11" pm="."><plain>The treatment schedules were very different between the two centres </plain></SENT>
<SENT sid="12" pm="."><plain>More patients were treated with topical steroids in Japan (68.7% KUS vs 10.5% London (chi-square: 30.5; p=0.001), but a similar number used concomitant intraocular pressure-lowering agents </plain></SENT>
<SENT sid="13" pm="."><plain>More patients received systemic steroids in London (84.2% London vs 17% KUS (chi-square: 20.25; p&lt;0.001)) </plain></SENT>
<SENT sid="14" pm="."><plain>Three patients received systemic steroids alone, five had <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and cyclosporin, four had <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="2" ids="2948">azathioprine</z:chebi>, and four had triple therapy with <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, cyclosporin, and <z:chebi fb="2" ids="2948">azathioprine</z:chebi> </plain></SENT>
<SENT sid="15" pm="."><plain>Only one patient used <z:chebi fb="0" ids="23359">colchicine</z:chebi> </plain></SENT>
<SENT sid="16" pm="."><plain>Cyclosporin use was similar in London and KUS (47.4% and 42.8%, respectively) </plain></SENT>
<SENT sid="17" pm="."><plain>In Japan, three patients used <z:chebi fb="2" ids="8378">prednisolone</z:chebi> alone and three tacrolimus (FK506) </plain></SENT>
<SENT sid="18" pm="."><plain>In addition, two patients, who were on steroids alone, took <z:chebi fb="0" ids="23359">colchicine</z:chebi> as well </plain></SENT>
<SENT sid="19" pm="."><plain>More patients in Japan had undergone surgery for <z:hpo ids='HP_0000518'>cataract</z:hpo> and <z:hpo ids='HP_0000501'>glaucoma</z:hpo> (chi-square: 4.0; p=0.045) </plain></SENT>
<SENT sid="20" pm="."><plain>In KUS, seven of 67 eyes had <z:hpo ids='HP_0000518'>cataract</z:hpo> surgery </plain></SENT>
<SENT sid="21" pm="."><plain>A further three eyes had visually significant <z:hpo ids='HP_0000518'>cataract</z:hpo> and two eyes had undergone <z:hpo ids='HP_0000501'>glaucoma</z:hpo> surgery </plain></SENT>
<SENT sid="22" pm="."><plain>In contrast, no patients in London had undergone any surgery up to and including this period </plain></SENT>
</text></document>